XML 17 R12.htm IDEA: XBRL DOCUMENT v2.3.0.15
Derivative Instruments
9 Months Ended
Sep. 30, 2011
Notes to Financial Statements 
Derivative Instruments

 

Derivative instruments

 

We use derivatives to manage certain risks in our general account portfolio as well as our insurance liabilities. Our derivatives do not qualify for hedge accounting treatment and are stated at fair value (market value) within other investments on our balance sheet, with changes in valuation reported in net realized investment gains/losses on our statements of income. The Company seeks to enter into over-the-counter (“OTC”) derivative transactions pursuant to master agreements that provide for a netting of payments and receipts by counterparty. As of September 30, 2011 and December 31, 2010, $7,510 thousand and $6,870 thousand, respectively, of cash and cash equivalents were held as collateral by a third party related to our derivative transactions.

 

 

Derivative Instruments Held in         Fair Value as of   Fair Value as of
General Account:         September  30, 2011   December  31, 2010
($ in thousands) Notional                    
  Amount   Maturity   Asset   Liability   Asset   Liability
Non-hedging derivative instruments                                
   Interest rate swaps $ 101,000     2017-2026   $ 11,010     $ 3,634     $ 3,593     $ 1,469  
   Variance swaps   935     2015-2017     3,174       --       --       577  
   Swaptions   25,000     2024     180       --       2,097       --  
   Put options   205,000     2016-2021     57,944       --       45,019       --  
   Call options   367,153     2011-2016     11,389       6,843       11,231       5,980  
   Equity futures   136,725     2011     24,039       --       28,501       --  
Total non-hedging derivative instruments $ 835,813         $ 107,736     $ 10,477     $ 90,441     $ 8,026  

 

Derivative Instrument Gains (Losses) Recognized in Earnings:(1) Three Months Ended   Nine Months Ended
($ in thousands) September  30,   September  30,
  2011   2010   2011   2010
Derivative instruments by type                      
   Interest rate swaps $ 6,870     $ 1,680     $ 11,146     $ 4,413  
   Variance swaps   5,404       --       3,751       --  
   Swaptions   (420)     737       (826)     1,907  
   Put options   23,010       (10,804)     18,010       21,582  
   Call options   (10,642)     (180)     (13,925)     (893)
   Equity futures   16,380       (12,549)     10,575       (10,105)
   Cross currency swaps   --       --       --       --  
Total derivative instrument gains (losses) recognized in earnings $ 40,602     $ (21,116)   $ 28,731     $ 16,904  

———————

(1) Excludes realized losses of $46,138 thousand and realized gains of $13,743 thousand on embedded derivatives for the three months ended September 30, 2011 and 2010 and realized losses of $41,630 thousand and $15,625 thousand on embedded derivatives for the nine months ended September 30, 2011 and 2010.

 

Interest Rate Swaps

 

We maintain an overall interest rate risk-management strategy that primarily incorporates the use of interest rate swaps as hedges of our exposure to changes in interest rates. Our exposure to changes in interest rates primarily results from our commitments to fund interest-sensitive insurance liabilities, as well as from our significant holdings of fixed rate financial instruments. We use interest rate swaps that effectively convert variable rate cash flows to fixed cash flows in order to hedge the interest rate risks associated with guaranteed minimum living benefit (GMAB/GMWB) rider liabilities.

 

Interest Rate Options

 

We use interest rate options, such as swaptions, to hedge against market risks to assets or liabilities from substantial changes in interest rates. An interest rate swaption gives us the right but not the obligation to enter into an underlying swap. Swaptions are options on interest rate swaps. All of our swaption contracts are receiver swaptions, which give us the right to enter into a swap where we will receive the agreed-upon fixed rate and pay the floating rate. If the market conditions are favorable and the swap is needed to continue hedging our inforce liability business, we will exercise the swaption and enter into a fixed rate swap. If a swaption contract is not exercised by its option maturity date, it expires with no value.

 

Exchange Traded Future Contracts

 

We use equity index futures to hedge the market risks from changes in the value of equity indices, such as S&P 500, associated with guaranteed minimum living benefit (GMAB/GMWB) rider liabilities. Positions are short-dated, exchange-traded futures with maturities of three months.

 

Equity Index Options

 

The Company uses equity indexed options to hedge against market risks from changes in equity markets, volatility and interest rates.

 

An equity index option affords the Company the right to make or receive payments based on a specified future level of an equity market index. The Company may use exchange-trade or OTC options.

 

Generally, the Company has used a combination of equity index futures, interest rate swaps, variance swaps and long-dated put options to hedge its GMAB and GMWB liabilities and equity index call options to hedge its indexed annuity option liabilities.

 

Contingent features

 

Derivative counterparty agreements may contain certain provisions that require our insurance companies’ financial strength rating to be above a certain threshold. If our financial strength ratings were to fall below a specified rating threshold, certain derivative counterparties could request immediate payment or demand immediate and ongoing full collateralization on derivative instruments in net liability positions, or trigger a termination of existing derivatives and/or future derivative transactions.

 

In certain derivative counterparty agreements, our financial strength ratings remain below the specified threshold levels as a result of rating downgrades in early 2009. However, the Company held no derivative instruments as of September 30, 2011 in a net liability position payable to any counterparty (i.e., such derivative instruments have fair values in a net asset position payable to the Company if such holdings were liquidated).